These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31477057)

  • 1. Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.
    Petzold F; Bachmann A; Bergmann C; Helmchen U; Halbritter J
    BMC Nephrol; 2019 Sep; 20(1):340. PubMed ID: 31477057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful renal transplantation in a family with a novel mutation in COL4A3 gene and autosomal recessive Alport syndrome.
    Girimaji N; Murugan Sm S; Nada R; Sharma A; Rathi M; Kohli HS; Gupta KL; Ramachandran R
    Nephrology (Carlton); 2020 Jun; 25(6):497-501. PubMed ID: 31925849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
    Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
    Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
    Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene.
    Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A
    Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous Urinary Abnormality-Causing Variants of
    Horinouchi T; Yamamura T; Nagano C; Sakakibara N; Ishiko S; Aoto Y; Rossanti R; Nakanishi K; Shima Y; Morisada N; Iijima K; Nozu K
    Kidney360; 2020 Sep; 1(9):936-942. PubMed ID: 35369551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.
    Caliskan Y; Lentine KL
    Pediatr Nephrol; 2022 Sep; 37(9):1981-1994. PubMed ID: 35088158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Cryptic Mosaicism in X-linked Alport Syndrome Prompts to Re-evaluate Living-donor Kidney Transplantation.
    Pinto AM; Daga S; Fallerini C; Bruttini M; Baldassarri M; Giliberti A; Frullanti E; Guarnieri A; Garosi G; Renieri A
    Transplantation; 2020 Nov; 104(11):2360-2364. PubMed ID: 31895869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to resolve confusion in the clinical setting for the diagnosis of heterozygous COL4A3 or COL4A4 gene variants? Discussion and suggestions from nephrologists.
    Imafuku A; Nozu K; Sawa N; Nakanishi K; Ubara Y
    Clin Exp Nephrol; 2020 Aug; 24(8):651-656. PubMed ID: 32232700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of clinical characteristics and genetic backgrounds in Alport syndrome.
    Nozu K; Nakanishi K; Abe Y; Udagawa T; Okada S; Okamoto T; Kaito H; Kanemoto K; Kobayashi A; Tanaka E; Tanaka K; Hama T; Fujimaru R; Miwa S; Yamamura T; Yamamura N; Horinouchi T; Minamikawa S; Nagata M; Iijima K
    Clin Exp Nephrol; 2019 Feb; 23(2):158-168. PubMed ID: 30128941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for Genetic Testing and Management of Alport Syndrome.
    Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
    Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.
    Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E
    BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudodominant Alport syndrome caused by pathogenic homozygous and compound heterozygous COL4A3 splicing variants.
    Mohamed M; Tellez J; Bergmann C; Gale DP; Sayer JA; Olinger E
    Ann Hum Genet; 2022 May; 86(3):145-152. PubMed ID: 34888854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mutation in the COL4A3 gene responsible for autosomal dominant Alport syndrome, which only generates hearing loss in some carriers.
    Rosado C; Bueno E; Fraile P; García-Cosmes P; González-Sarmiento R
    Eur J Med Genet; 2015 Jan; 58(1):35-8. PubMed ID: 25450602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
    Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
    Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting presentation of two rare genetic variants of autosomal dominant polycystic kidney disease and Alport syndrome.
    Venda J; Henriques A; Leal R; Alves R
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38740443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
    Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
    Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor kidney transplantation in patients with hereditary nephropathies.
    Niaudet P
    Nat Rev Nephrol; 2010 Dec; 6(12):736-43. PubMed ID: 20877305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel COL4A3 gene mutations in a consanguineous family with autosomal recessive Alport syndrome.
    Sirisena ND; Thalgahagoda S; Abeyagunawardena A; Neumann M; Schmudlach HO; Jayasekara RW; Dissanayake VH
    Nephrology (Carlton); 2015 Aug; 20(8):580. PubMed ID: 26194984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.